1 KOCAK I, KOC H. Comparison of Densiron 68 and 1 000 cSt silicone oil in the management of rhegmatogenous retinal detachment with inferior breaks[J]. Int J Ophthalmol,2013,6(1):81-84.
2 Russo A, Morescalchi F, Donati S, Gambicorti E, Azzolini C, Costagliola C, Semeraro F: Heavy and standard silicone oil: intraocular inflammation. Int Ophthalmol 2018; 38: 855-867. DOI:10.1007/s10792-017-0489-3
3 Semeraro F, Russo A, Morescalchi F, Gambicorti E, Vezzoli S, Parmeggiani F, Romano MR, Costagliola C: Comparative assessment of intraocular inflammation following standard or heavy silicone oil tamponade: a prospective study. Acta Ophthalmol 2019; 97: e97-97e102. DOI:10.1111/aos.13830
4 Donati S, Caprani SM, Airaghi G, Vinciguerra R, Bartalena L, Testa F, Mariotti C, Porta G, Simonelli F, Azzolini C: Vitreous substitutes: the present and the future. Biomed Res Int 2014; 2014: 351804. DOI:10.1155/2014/351804
5 TIWARI S, BAHADUR P. Modified hyaluronic acid based materials for biomedical applications[J]. Int J Biol Macromol,2019,121:556-571.
6 FAKHARI A, BERKLAND C. Applications and emerging trends of hyaluronic acid in tissue engineering, as a dermal filler and in osteoarthritis treatment[J]. Acta Biomater,2013,9(7):7081-7092.
7 HONG Y, CHIRILA T V, VIJAYASEKARAN S, et al. Biodegradation in vitro and retention in the rabbit eye of crosslinked poly(1-vinyl-2-pyrrolidinone) hydrogel as a vitreous substitute[J]. J Biomed Mater Res,1998,39(4):650-659.
8 HONG Y, CHIRILA T V, VIJAYASEKARAN S, et al. Crosslinked poly(1-vinyl-2-pyrrolidinone) as a vitreous substitute[J]. J Biomed Mater Res,1996,30(4):441-448.
9 LEE B, LITT M, BUCHSBAUM G. Rheology of the vitreous body. Part I: Viscoelasticity of human vitreous[J]. Biorheology,1992,29(5-6):521-533.
10 LEE B, LITT M, BUCHSBAUM G. Rheology of the vitreous body: Part 2. Viscoelasticity of bovine and porcine vitreous[J]. Biorheology,1994,31(4):327-338.
11 KIRCHHOF B, TAVAKOLIAN U, PAULMANN H, et al. Histopathological findings in eyes after silicone oil injection[J]. Graefes Arch Clin Exp Ophthalmol,1986,224(1):34-37.
12 FOSTER W J. Vitreous Substitutes[J]. Expert Rev Ophthalmol,2008,3(2):211-218.
13 SILVER F H, LIBRIZZI J, BENEDETTO D. Use of viscoelastic solutions in ophthalmology: a review of physical properties and long-term effects[J]. J Long Term Eff Med Implants,1992,2(1):49-66.
14 NAKAGAWA M, TANAKA M, MIYATA T. Evaluation of collagen gel and hyaluronic acid as vitreous substitutes[J]. Ophthalmic Res,1997,29(6):409-420.
15 SCHRAMM C, SPITZER M S, HENKE-FAHLE S, et al. The cross-linked biopolymer hyaluronic acid as an artificial vitreous substitute[J]. Invest Ophthalmol Vis Sci,2012,53(2):613-621.
16 Januschowski K, Schnichels S, Hurst J, Hohenadl C, Reither C, Rickmann A, Pohl L, Bartz-Schmidt KU, Spitzer MS: Ex vivo biophysical characterization of a hydrogel-based artificial vitreous substitute. PLoS One 2019; 14: e0209217. DOI:10.1371/journal.pone.0209217
17 D'Errico G, De Lellis M, Mangiapia G, Tedeschi A, Ortona O, Fusco S, Borzacchiello A, Ambrosio L: Structural and mechanical properties of UV-photo-cross-linked poly(N-vinyl-2-pyrrolidone) hydrogels. Biomacromolecules 2008; 9: 231-240. DOI:10.1021/bm7008137
18 Noshadi I, Hong S, Sullivan KE, Shirzaei Sani E, Portillo-Lara R, Tamayol A, Shin SR, Gao AE, Stoppel WL, Black LD I, Khademhosseini A, Annabi N: In vitro and in vivo analysis of visible light crosslinkable gelatin methacryloyl (GelMA) hydrogels. Biomater Sci 2017; 5: 2093-2105. DOI:10.1039/c7bm00110j